Title:
BETA-CASEIN A2 AND BLOOD GLUCOSE LEVELS
Document Type and Number:
Japanese Patent JP2019011342
Kind Code:
A
Abstract:
To prevent or minimize epigenetic changes of one or more genes, being a cause of glucose homeostasis and insulin signaling in an animal.SOLUTION: A composition contains beta-casein, the beta-casein containing a beta-casein variant having proline at position 67 of the beta-casein amino acid sequence, of at least 75% by weight.SELECTED DRAWING: Figure 1
Inventors:
ANDREW JOHN CLARKE
Application Number:
JP2018175833A
Publication Date:
January 24, 2019
Filing Date:
September 20, 2018
Export Citation:
Assignee:
A2 MILK COMPANY LTD
International Classes:
A61K38/17; A23C9/00; A23C9/12; A23C13/00; A23C15/00; A23C19/00; A23G9/38; A23L33/17; A61P3/04; A61P3/08; A61P3/10; A61P9/00; A61P13/02; A61P13/12; A61P43/00
Domestic Patent References:
| JP2003503038A | 2003-01-28 | |||
| JP2006501299A | 2006-01-12 | |||
| JP2005531325A | 2005-10-20 |
Foreign References:
| WO1996014577A1 | 1996-05-17 |
Other References:
ＪＯＵＲＮＡＬ ＯＦ ＡＰＰＬＩＥＤ ＧＥＮＥＴＩＣＳ, vol. 48, no. 3, JPN6018017650, 2007, pages 189 - 198, ISSN: 0004465907
ＣＬＩＮＩＣＡＬ ＰＨＡＲＭＡＣＯＬＯＧＹ ＡＮＤ ＴＨＥＲＡＰＥＵＴＩＣＳ, vol. 92, no. 6, JPN6019029765, 2012, pages 707 - 715, ISSN: 0004465908
ＤＩＡＢＥＴＯＬＯＧＩＡ, vol. 56, no. 5, JPN6019029768, 2013, pages 1036 - 1046, ISSN: 0004465909
ＣＬＩＮＩＣＡＬ ＰＨＡＲＭＡＣＯＬＯＧＹ ＡＮＤ ＴＨＥＲＡＰＥＵＴＩＣＳ, vol. 92, no. 6, JPN6019029765, 2012, pages 707 - 715, ISSN: 0004465908
ＤＩＡＢＥＴＯＬＯＧＩＡ, vol. 56, no. 5, JPN6019029768, 2013, pages 1036 - 1046, ISSN: 0004465909
Attorney, Agent or Firm:
Shinjiro Ono
Osamu Yamamoto
Ichinomiya
Osamu Yamamoto
Ichinomiya